IP Library Granted Patent US 9,931,268
Granted Patent B2
US 9,931,268 · App. 14/485,094 · Granted Apr 3, 2018

Reduced pressure treatment system having blockage clearing and dual-zone pressure protection capabilities

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,931,268
App. No.
14/485,094
Granted
Apr 3, 2018
Kind
B2
Abstract

A method of treating a tissue site is provided. The method includes applying a reduced pressure to a tissue site with a reduced pressure source. A source pressure is monitored at the reduced pressure source, and a differential pressure is determined between the source pressure and the desired tissue site pressure. If a blockage is present between the reduced pressure source and the tissue site, the differential pressure is limited to a first maximum differential pressure. If no blockage is present between the reduced pressure source and the tissue site, the differential pressure is limited to a second maximum differential pressure.

Claims (18)

1. Apparatus for detecting a blockage between a tissue site and a reduced pressure source fluidly connected to the tissue site, comprising:

a first processor including a first sensing device and configured to measure a tissue-site pressure (TSP) proximate the tissue site corresponding to the pressure at the tissue site;

a second processor configured to measure a source pressure (SP) proximate to the reduced pressure source corresponding to the output of the reduced pressure source; and

a control processor in communication with the first processor and the second processor to regulate the output of the reduced pressure source in response to the source pressure (SP), the control processor having a first input adapted to be set at a target pressure desired for therapy at the tissue site (TP) and a second input adapted to be set at a first maximum differential pressure (DP1) above the target pressure (TP), and the control processor being configured to (i) determine if the tissue-site pressure TSP is less than the target pressure TP, (ii) calculate a differential pressure (DP) being the difference between the source pressure (SP) and the target pressure (TP), and (iii) determine if the differential pressure (DP) is greater than or equal to the first maximum differential pressure (DP1), and determine whether a change in the source pressure (SP) results in a directionally corresponding change in the tissue-site pressure (TSP).

2. The apparatus according to claim 1 , wherein the first maximum differential pressure (DP1) is less than about 50 mm Hg.

3. The apparatus according to claim 1 , wherein the control processor is further configured to prevent the source pressure (SP) from increasing further if (i) the tissue-site pressure TSP is less than the target pressure (TP), (ii) the differential pressure (DP) is greater than or equal to the first maximum differential pressure (DP1), and (iii) a change in the source pressure (SP) does not result in a directionally corresponding change in the tissue-site pressure (TSP).

4. The apparatus according to claim 3 , wherein the control processor further comprises an alarm device to alert a user of the presence of a blockage between the reduced pressure source and the tissue site.

5. The apparatus according to claim 3 , wherein the first maximum differential pressure (DP1) is less than about 50 mm Hg.

6. The apparatus according to claim 1 , wherein the control processor is further configured to allow the source pressure (SP) to increase further if (i) the tissue-site pressure TSP is less than the target pressure (TP), (ii) the differential pressure (DP) is greater than or equal to the first maximum differential pressure (DP1), and (iii) a change in the source pressure (SP) does result in a directionally corresponding change in the tissue-site pressure (TSP) confirming no blockage between the reduced pressure source and the tissue site.

7. The apparatus according to claim 6 , wherein the first maximum differential pressure (DP1) is less than about 50 mm Hg.

8. The apparatus according to claim 6 , wherein the control processor further comprises a third input adapted to be set as a second maximum differential pressure (DP2) greater than the target pressure (TP).

9. The apparatus according to claim 8 , wherein the second maximum differential pressure (DP2) is greater than the first maximum differential pressure (DP1).

10. The apparatus according to claim 9 , wherein the first maximum differential pressure (DP1) is less than about 50 mm Hg.

11. The apparatus according to claim 10 , wherein the second maximum differential pressure is less than about 100 mm Hg.

12. The apparatus according to claim 10 , wherein the control processor is further configured to prevent the source pressure (SP) from increasing further if the differential pressure (DP) is greater than or equal to the second maximum differential pressure (DP2).

13. The apparatus according to claim 12 , wherein the control processor further comprises an alarm device to alert a user that the differential pressure (DP) is greater than or equal to the second maximum differential pressure (DP2).

14. The apparatus according to claim 1 , wherein the second processor includes a second sensing device.

15. The apparatus according to claim 14 , further comprising a canister fluidly connected between the tissue site and the reduced pressure source, and wherein the second sensing device measures the source pressure (SP) at the canister to approximate a pressure output of the reduced pressure source.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066432/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2017
From: KELCH, RANDALL P.; ZHENG, XIAOLU; EDGAR, REUBEN W., JR.; JAEB, JONATHAN PAUL; LAWHORN, THOMAS PAUL; INGRAM, SHANNON C.
To: KCI LICENSING, INC.
Reel/Frame 044075/0437 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →